03:56 AM EDT, 08/08/2024 (MT Newswires) -- Verona Pharma ( VRNA ) reported a Q2 net loss Thursday of $0.11 per diluted share, compared with a loss of $0.01 a year earlier.

Analysts polled by Capital IQ expected a per-share loss of $0.21.

As expected, the company didn't report any revenue for the quarter ended June 30.

At the end of June, Verona had cash and cash equivalents of $404.6 million

Price: 20.38, Change: +0.85, Percent Change: +4.35